Curaçao
Diabetes country report 2024 — 2050
Number of adults (20–79 years) with diabetes in Curaçao (CW)
2024 | 22.1 thousand |
2050 | 25.2 thousand |
Curaçao is one of the 22 countries and territories in the IDF North America and Caribbean Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Aruba, Bahamas, Barbados, Grenada, Haiti, Jamaica, St Kitts and Nevis, St Vincent and the Grenadines and Trinidad and Tobago.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | - | 22.1 | 25.2 |
Age-standardised prevalence of diabetes, % | - | - | 13.4 | 15.4 |
Proportion of people with undiagnosed diabetes, % | - | - | 24.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 5.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 6.2 | 6.7 |
Age-standardised prevalence of IFG, % | - | - | 4.1 | 4.3 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | - | 8.8 | 9.9 |
Age-standardised prevalence of IGT, % | - | - | 5.5 | 6.2 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | - | 185.3 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 15.9 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | - | - |
Total diabetes-related health expenditure, ID million | - | - | - | - |
Diabetes-related health expenditure per person, USD | - | - | - | - |
Diabetes-related health expenditure per person, ID | - | - | - | - |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 115.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 15.1 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | - | 142.5 | 149.5 |
Population of children and adolescents (0-19 y) | - | - | 38,183.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |